Page results
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
UCLH has two mortuaries, one at University College Hospital and one at the National Hospital for Neurology and Neurosurgery (NHNN)
-
Clinical Biochemistry HSL at 60 Whitfield Street has a fully automated laboratory offering a range of routine biochemical tests to UCLH and local GPs.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
The snoring and sleep disorders clinic offers, out-patient consultation including flexible endoscopy to assess upper airway collapse. Multidisciplinary team involvement for planning treatment.
-
The specialist allergy and clinical immunology service deals with the diagnosis and management of allergies and related immune system disorders in adults.
-
The Neurogenetics Unit offers a fully integrated service encompassing clinical assessment, diagnosis, molecular genetic testing and counselling for neurogenetic conditions.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
File results
-
FOI/2023/0215 - British sign language procurement and communications
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0227 - Number of radiographers and nuclear medicine clinical scientists at Trust
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas